How COVID-19 is changing wound care: New triage models, metabolic inflammation in diabetes, and the need for international consensus


Speaking from four separate rooms in four different corners of the world, William Ennis, Desmond Bell, Michael Edmonds, and William Li expounded over zoom on the myriad ways in which COVID-19 had impacted multidisciplinary wound care, both in terms of the disruption the pandemic had caused to their daily practices, and how the echoes of this disruption would ripple into the future. They also touched on the interrelationship between diabetes and COVID-19, questioning what the downstream effects will be in the vulnerable diabetic population.

William Ennis (University of Illinois, Chicago, USA), president of the American College of Wound Healing and Tissue Repair and chief medical officer of Healogics, moderated the panel discussion. Desmond Bell is the founder and president of the non-profit organisation Save A Leg, Save A Life Foundation, and chief medical officer at Omeza. Michael Edmonds is a diabetologist at King’s College Hospital, London, UK. William Li is an internal medicine physician at Harvard Medical School, Cambridge, USA, the CEO, president, and medical director of the Angiogenesis Foundation, and a board member of the American College of Wound Healing and Tissue Repair.


Please enter your comment!
Please enter your name here